Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Pain is Inevitable, Misery is Optional: Emotion Regulation Skills in Pain Treatment (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about emotional regulation skills used in the chronic and acute pain population for a more comprehensive treatment approach from The ASAM 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Recently there has been research and a better understanding of the interactions among, biological, psychological and social factors that affect health and illness.  This has led to a paradigm shift from a biomedical reductionism approach to a more comprehensive biopsychosocial model.  This interaction is apparent in working with chronic and acute pain patients where mental health, addiction and medical pathologies prominently interface.  Research has shown that this combination in pain disorders creates challenges in self-regulation and increases the possibility of acquiring a substance use disorder and/or addiction.  Emotion regulation skills play a vital role in working through the challenges this population will encounter for better outcomes, acceptance of the pain disorder and its accompanying emotional and mental concerns and teaching patient’s self-regulation skills to effectively work through the pain without depending primarily on opiate prescriptions.  This presentation focuses on effective emotion regulation skills used in the chronic and acute pain population for a more comprehensive treatment approach.  These skills affectively target and help manage mental health conditions, addiction and related behavioral difficulties, distressing emotions and physical pain symptoms while increasing successful outcomes.  


    Learning Objectives:

    1.) Understand the biospychosocial model and the importance of behavioral health in chronic and acute pain treatment
    2.) Describe emotion regulation skills used with chronic/acute and dually diagnosed patients
    3.) Practice a sampling of successful emotion regulation skills



    Osvaldo Cabral

    MA, LPC, LAC

    Osvaldo “Ozzie” Cabral has worked in addiction and mental health since 2002.  His areas of expertise include Addiction Treatment, Dialectical Behavior Therapy, Skills Training, Schema-Focused Therapy, working with the chronically mentally ill and treating dually diagnosed clients. Additional areas of specialization include Aggression Replacement Training, Cognitive Behavioral Therapy, Pain Treatment and Trauma-Focused Therapies. As Director of Integrated Services, he coordinates the operations of New Health’s medical and behavioral health professionals to ensure continuity of care for New Health patients.  Ozzie also co-founded and operates “Song of the Wolf Healing Center” which is a wolf and wolf-dog rescue in Bailey, Colorado.

    Bari Platter

    MS, RN, PMHCNS-BC

    Bari Platter is a Clinical Nurse Specialist at the University of Colorado Hospital

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Keys to Building Successful Fellowship Training Programs (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning how to help contribute to the growth of the fellowship workforce from the 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    In less than a decade, Addiction Medicine fellowship programs have established themselves as central to the discipline’s emergence and expansion as the newest formally recognized medical subspecialty. The number of physicians in these training programs has grown steadily, and they are proving their value in patient care, medical education, and health system leadership. Nevertheless, the majority of medical schools and teaching hospitals still do not have fellowships, and additional programs are needed to meet the critical shortage of addiction medicine workforce. This workshop will provide valuable insights for those who wish to lead or play a role in responding to this need. The expert panel includes experienced fellowship program directors who also have leadership positions in the American College of Academic Addiction Medicine (the new successor organization to The Addiction Medicine Foundation and the Addiction Medicine Fellowship Directors Association). In the first part of the workshop, the panelists will take participants through the fellowship development process based on their own experiences with issues including funding strategies, faculty recruitment and clinical rotation design. Each panelist represents a different primary specialty (Family Medicine, Internal Medicine, Pediatrics and Psychiatry), giving participants a unique opportunity to compare fellowship design options in this multispecialty subspecialty. The second part of the workshop will feature breakout groups in which participants will work with an application form from the Accreditation Council for Graduate Medical Education (ACGME). Under the guidance of the panelists, each group will complete one key part of the application (e.g., inpatient rotations, outpatient rotations, didactics and scholarly activities), then report out on their draft. The panel (whose members have also been involved in developing the ACGME requirements for Addiction Medicine) will then reassemble to offer comments on the drafts and suggestions for improvement. Ample time will be provided for questions and discussion, and all participants will be offered the opportunity for ongoing technical assistance.  


    Learning Objectives:

    1.) Describe the key requirements for accreditation of an Addiction Medicine fellowship training program.
    2.) Design a clinical rotation for teaching patient care competencies in Addiction Medicine.
    3.) Identify didactic activities for teaching medical knowledge competencies in Addiction Medicine.



    Lon R. Hays

    MD, MBA, DFAPA, DFASAM

    Lon Roberts Hays, M.D., M.B.A. graduated from medical school at the University of Kentucky in 1982 then pursued residency training at the University of Kentucky, which he completed in 1986. At that time he joined the faculty in the Department of Psychiatry where he has served as Chair from 1998 to 2018, and is director of the Addiction Medicine Fellowship.  In addition to being Board Certified by the American Board of Psychiatry and Neurology, Dr. Hays also is certified by the American Board of Addiction Medicine and has Added Qualifications in both Addiction Psychiatry and Geriatric Psychiatry. He completed a Certificate of Medical Management in 1998 and went on to obtain his M.B.A. from the University of Kentucky Gatton School of Business in May 2001.  Dr. Hays is a Co-investigator on numerous grants involving drugs of abuse.  He is the Director of Area V of the American Academy of Addiction Psychiatry, President of the Addiction MedicineFoundation, a Distinguished Fellow of the American Psychiatric Association, and an elected member and Fellow of the American College of Psychiatrists."

    Randall T. Brown

    MD, PhD, DFASAM

    Dr. Brown is Board Certified in Family Medicine and Addiction Medicine and has 17 years of clinical and teaching experience in these two specialty areas, as well as research training and applied, published research experience with a focus upon addiction health services research. He provides consultation for substance use disorders at Federally Qualified Health Centers (Access Community Health Centers), at 3 hospitals, and at the Univeristy of Wisconsin's HIV/AIDS Clinic in Madison, WI. He has completed fellowships in research methods (NRSA Primary Care Research Fellowship) and academic career development (Alcohol Medical Scholars Program, UCSF Faculty Development Fellowship). He also completed a doctoral dissertation in Population Health Sciences with a focus on Addiction Health Services Research with an additional certificate in Clinical Investigations. He is a Director of the American College of Academic Addiction Medicine (ACAAM) and the Chair of ACAAM's Fellowship Directors Committee. He is the founding director of 2 addiction medicine (ADM) fellowship programs at UW and at the Madison VA Medical Center. He co-authored ADM Fellowship Program Requirements for submission to the American Council on Graduate Medical Education. He is additionally experienced in leadership and collaboration on NIH, VA, SAMHSA, HRSA and other (intramural and private) funding awards. In the last 5 years, he has served as PI (10 awards) or co-investigator (7 awards) on 17 successful applications resulting in more than $14 million in funding, 22 peer-reviewed publications, and 35 abstracts accepted for regional and national presentations during that time. He has contributed extensively to other published efforts aiming to educate physicians in training on substance-related issues, including 7 book chapters, practice questions for the ADM Board Examination, and SAMHSA Treatment Improvement Protocols.

    Jeanette M. Tetrault

    MD, FACP, FASAM

    Dr. Tetrault’s scholarly work focuses on care of patients with addicition and the medical co-morbidities associated with substance use, mainly HIV and Hepatitis C. She is a diplomate of the American Board of Addiction Medicine. Dr. Tetrault is a physician providing primary care and buprenorphine/naloxone treatment at the Central Medical Unit of the APT Foundation, a multi-specialty addiction treatment facility, and is an attending physician at Yale New Haven Hospital (YNHH). She is the co-director of the Addiction Recovery Clinic in the Adult Primary Care Clinic at the St. Raphael's Campus of YNHH, which serves both a clinical care and a teaching mission. She was selected as a Macy Foundation Faculty Scholar in 2017. She is the Program Director for the Yale Addiction Medicine Fellowship Program and serves on the Board of Directors for The Addiction Medicine Foundation and the Addiction Medicine Fellowship Directors Association. She is a past-president of the New England Region of SGIM and co-chair of the Alcohol, Tobacco and Other Drug Use Interest Group for SGIM.

    Timothy K. Brennan

    MD, MPH, FASAM

    Timothy Brennan, MD, MPH, FASAM is an Addiction Medicine physician and Pediatrician. He is the Director of the Addiction Institute at Mount Sinai West and St. Luke's Hospitals in New York City and the Vice President for Medical and Academic Affairs at The Addiction Medicine Foundation. He is also the Director of the Fellowship in Addiction Medicine at the Icahn School of Medicine at Mount Sinai. He completed a Fellowship in Addiction Medicine at the Addiction Institute of New York, a Fellowship in Medical Ethics at Harvard Medical School, a Residency in Pediatrics at Weill Cornell Medical College / New York Presbyterian Hospital, and an Internship in Internal Medicine at Georgetown University Hospital. He is the Co-Editor of Essentials of Addiction Medicine and Board Certified in Addiction Medicine and Pediatrics.

    Andrew A. Danzo

    BA

    Andrew Danzo is Director of Fellowship Development for The American College of Academic Addiction Medicine (formerly The Addiction Medicine Foundation). He has been involved in developing fellowship training programs since 2010 as part of the successful effort to build a graduate medical education infrastructure for Addition Medicine and achieve its formal recognition by the American Board of Medical Specialties and the Accreditation Council for Graduate Medical Education. Based in the Department of Family Medicine at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Mr. Danzo has also worked on a variety of projects, including faculty development, the New York State Rural Health Research Center and New York State Area Health Education Center. From 2000-2009, he served as Associate Editor of The Journal of Rural Health. He earned a BA in economics and political science from Rutgers University and previously worked for a number of years as a journalist.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Becoming Certified in Addiction Medicine through ABPM (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the requirements and various pathways available for physicians to apply for eligibility to sit for the Addiction Medicine subspecialty exam from the 50th Annual Conference (2019).

    Starting in the spring of 2017, the American Board of Preventive Medicine (ABPM) began offering physicians who are certified by a Member Board of the American Board of Medical Specialties (ABMS) the opportunity to apply and become certified in the subspecialty of Addiction Medicine. Michael Weaver, MD, DFASAM, Addiction Medicine Subboard Chair, and Chris Ondrula, JD, Executive Director of ABPM, will review the requirements and various pathways, i.e., Practice Pathway and Fellowship, available for physicians to apply for eligibility to sit for the Addiction Medicine subspecialty exam. This includes a streamlined process for application for those who are already certified by the American Board of Addiction Medicine (ABAM). Information on the timeline for the 2019 application cycle, dates for the examination period, and fee schedule will also be made available.  Information will also be provided for attendees who are already certified in Addiction Medicine by ABPM about maintenance of certification (MOC). Ample time will be provided for questions from the attendees. For more information visit the ABPM booth in the exhibit hall or www.theabpm.org.  

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:


    Learning Objectives:

    1.) Identify the different pathways to certification in Addiction Medicine through ABPM.
    2.) Recognize requirements to be eligible for certification in Addiction Medicine through ABPM.
    3.) Discuss requirements and available options for maintenance of certification (MOC) in Addiction Medicine through ABPM.



    Michael F. Weaver

    MD, DFASAM

    Dr. Michael Weaver is Professor of Psychiatry and Medical Director of the Center for Neurobehavioral Research on Addiction at The University of Texas McGovern Medical School at Houston. He completed a Residency in Internal Medicine and a Clinical Research Fellowship in Addiction Medicine at Virginia Commonwealth University. He is involved in patient care, medical education, and research. Dr. Weaver has multiple publications in the field of addiction medicine. He treats patients at the Innovations Addiction Treatment Clinic at the Texas Medical Center in Houston, which provides medication-assisted treatment. He is the Sub-Board Chair for Addiction Medicine for the American Board of Preventive Medicine.  He is a member of the ASAM Publications Council and on the Editorial Board for the Journal of Addiction Medicine.

    Christopher Ondrula

    JD

    Christopher J. Ondrula, JD Executive Director of the American Board of Preventive Medicine Currently, Mr. Ondrula is the Executive Director for the American Board of Preventive Medicine (ABPM).  As Executive Director, Mr. Ondrula works with the ABPM Board of Directors to develop and operationalize overall ABPM strategic initiatives through the planning and coordination of projects designed to advance ABPM’s goals.  That work includes the creation and implementation of a key performance indicator report that contains operational metrics and outcome measures that quantify organizational productivity and provides a platform for improved operational performance.  Mr. Ondrula is also responsible for formulating policies and strategic plans intended to identify fertile areas for the ABPM’s continued growth within the House of Medicine.  Previously, Mr. Ondrula was the Strategic Business Affairs & Legal Advisor for the American Board of Medical Specialties (ABMS).  In that role, Mr. Ondrula planned, organized and coordinated projects supporting key ABMS organizational strategic objectives, focusing on ways to improve efficiency.  Mr. Ondrula’s responsibilities at ABMS also included the CertLink Initiative where, among other things, he was chiefly responsible for development of the economic model to assess its viability, as well as his collaborative work with the Ethics and Professional Committee, and strategic efforts in support of the ABMS Legislative Team.  Prior to joining ABMS in 2015, Mr. Ondrula served as the Chief Executive Officer and Director at Heartland Food Corporation which, at the time was the 2nd largest Burger King franchisee in the -World, and, before that he was the Chief Operating Officer and General Counsel for Spence Group Services. Mr. Ondrula received his undergraduate degree in business from Miami University in Oxford, Ohio, and received his Juris Doctorate from Valparaiso University School of Law.  

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of XX AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of XX LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of XX AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn XX Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Maintaining Fidelity to Evidence-Based Criteria (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the ASAM Criteria from the 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Ongoing efforts to reform the nation’s addiction treatment system often focus on implementation of evidence-based practices. Implementing these practices with fidelity to the evidence-base can present significant challenges. While this culture shift will be difficult, it is necessary to ensure quality of treatment in an environment where quality has sometimes been compromised.  This session will take an in depth look at The ASAM Criteria and the tools that can help support fidelity in implementation including: the CARF ASAM Level of Care Certification program, The ASAM CONTINUUM Software, ASAM Criteria Training Courses, as well as changes to ASAM’s copyright and permissions processes related to The ASAM Criteria. The cost structures and time requirements for these tools and verifications will be discussed, as well as the interaction between the CARF certification and CARF and JCAHO accreditations.  Additionally, opportunities for ASAM members to participate in the educational endeavors and support systems for these endeavors will be listed.





    Paul H. Earley

    MD, DFASAM

    Dr. Earley has worked in Addiction Medicine for over 30 years. He treats all types of addictive disorders and specializes in the assessment, treatment and management of health care professionals. As a therapist, he works with patients already in recovery, providing long term therapy for those who suffer from this disease. His professional expertise extends to advocacy for professionals before agencies and licensing boards. 

    Dr. Earley is a dynamic speaker and educator; he speaks and trains on topics of addiction, its treatment and addiction among health care professionals. In addition, he trains therapists about the neurobiological basis of psychotherapy. In his travels, he has provided training in the United States, Canada, the United Kingdom, Italy, Iceland and Switzerland.

    He is the author of two books and several research articles on addiction and its treatment. His most recent book, RecoveryMind Training is an innovative and comprehensive process designed to reengineer addiction treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) Textbook: Principles of Addiction Medicine, as author of the chapter: Physician Health Programs and Addiction among Physicians. He is a contributing author to the ASAM Criteria. His work was featured in the documentary series on addiction entitled Close to Home by Bill Moyers.

    Currently, Dr. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program (PHP) for the state of Georgia and the President-elect of the Federation of State Physician Health Programs (FSPHP). Dr. Earley is the current president-elect of the American Society of Addiction Medicine (ASAM). He is a Distinguished Fellow of ASAM and has served on the board of ASAM for over 14 years in several capacities.

    Michael Johnson

    MA, CAP

    Michael W. Johnson, M.A., C.A.P. Michael is currently the Managing Director for Behavioral Health at CARF International, a role he has held since 2013.  In this role, Michael is responsible for the development of standards in behavioral health to maintain currency with the field, interfacing with regulatory entities and payers, consultation and training, and market development. Michael has more than 38 years of experience in the behavioral healthcare field.  He began his career in in behavioral health as a tech on a psychiatric inpatient unit in 1981, and since that time has worked in a variety of clinical, management, and C-level roles in both mental health and substance abuse agencies.  He has been a leader in the industry, providing expertise to national and state initiatives in quality, ethics, training, accreditation, and EMR adoption.  Michael is passionate about the use of data and technology in our industry, and is a tireless advocate for increasing performance in behavioral health.  He possesses a Master of Arts degree in Communications and a Bachelor of Arts degree in Interpersonal Communications from the University of Central Florida, and is a Certified Addictions Professional.

    David R. Gastfriend

    MD, DFASAM

    An addiction psychiatrist, Dr. Gastfriend is Senior Research Scientist at the Public Health Management Corp. At Harvard Medical School, he directed addiction research at Massachusetts General Hospital and was an investigator in the NIDA Cocaine Collaborative Study, NIAAA’s COMBINE Study and NIDA’s Clinical Trials Network. As Vice President at Alkermes, Inc., he directed publications on Vivitrol in clinical, criminal justice and health economics research. His research on the American Society of Addiction Medicine (ASAM) Criteria contributed to endorsement by most U.S. states, and VA/DOD. His 150 scientific publications include The ASAM Criteria and Addiction Treatment Matching. His CONTINUUM – The ASAM Criteria Decision Engine™ and ASAM’s CO-Triage™ assessment tools are being adopted nationwide. He co-founded DynamiCare Health™, a nationally-scalable technology for Contingency Management and predictive analytics, winning Harvard Business School’s new venture global grand prize. He has consulted to the governments of Belgium, China, Iceland, Israel, Norway, Russia and the U.S.

    Margaret Jarvis

    MD, FASAM

    Margaret Jarvis, MD, has been the medical director of Marworth Treatment Facility in Waverly PA since 1999. She is credentialed by ABAM and ABPN in addiction and psychiatry. She has been very involved in work for ASAM and ABAM throughout her career.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Toxicovigilance of Novel Synthetic Substances using Social Media and Forum Data (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about trends related to Novel psychoactive substances (NPS) from The ASAM 50th Annual Conference (2019).

    (1 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Novel psychoactive substances (NPS) is defined in toxicological and addiction literature as the class of substances which have been either newly synthesized or involve pre- existing substances that are abused in novel ways. NPS have become increasingly abused in the United States in part due to their ease of access, availability on the internet, higher potency or longer duration of effect, and sometimes a loophole bypassing the laws of scheduled drugs. By 2015, over 700 such substances have been reported internationally. Of the subclasses, synthetic cathinones, synthetic cannabinoids and psychedelics/phenethylamines account for the largest portion of NPS reports. These drugs are often abused recreationally or as a means of “self-medicating” in order to moderate and/or potentiate the side effects of other drugs, or to treat symptoms such as anxiety and agitation. Because there is great variability in the effects, formulations, and potencies of these compounds, they have potential to cause significant morbidity and mortality. NPS are rapidly being developed and cleverly introduced into society in order to avoid legal implications. The literature detailing the effects and usages of these substances is scarce. As a result, providers rely on their prior experiences with “similar” medications in order to hypothesize how a NPS will effect someone. However, this has significant limitations. In order to respond to the rise of abuse and decrease complications, the medical community needs a better understanding of NPS. In an effort to better understand these substances and evaluate trends, our research group analyzed online forum discussions of users whom described personal experiences with a substance. We then performed a thematic analysis to characterize the study sample.  



    Learning Objectives: 

    1.) Better understand Novel Psychoactive Substances (NPS) by learning about their origin, prevalence, and legal controversies.  
    2.) Treat acute overdose, abuse, and complications of Novel Psychoactive Substances more comfortably.
    3.) Locate resources that will provide information about specific novel psychoactive substances in order to provide more comprehensive care for your patients.


    Vincent Ceretto

    DO, MS

    Vincent Ceretto DO, MA graduated Summa Cum Laude from SUNY University at Buffalo, Buffalo, NY and received his Master’s Degree in Anatomical and Pathological Sciences in 2012. He attended Lake Erie College of Osteopathic Medicine in Erie, Pennsylvania and graduated with his DO in 2016. Dr. Ceretto is currently completing Emergency Medicine Residency at the University of Rochester, Rochester, New York and will become a Fellow of Medical Toxicology at the University of Arizona, Banner Health, Phoenix, Arizona in July of 2019. Dr. Ceretto has special interests in Toxicology and Addiction Medicine. His research interests include understanding trends of the opioid crisis and toxicovigilance of novel psychoactive substances.

    Nels Grauman Neander

    DO, MASc

    Nels Grauman Neander DO, MASc attended McMaster University and graduated with a Master’s Degree in Chemical Engineering in 2012. He received his DO from Western Health Sciences University in Lebanon, Oregon in 2016. Dr. Grauman Neander is completing Emergency Medicine residency at the University of Rochester, Rochester, New York in June of 2019. He is a certified instructor of the ASAM Buprenorphine course and the FEMA Hospital Emergency Response for Mass Casualty Incidents Course. He is a certified Physician Builder and Analyst for Epic. Dr. Grauman Neander's research interests include Addiction Medicine, Toxicovigilance, Informatics and Disaster Medicine.

    Sonya Narla

    DO, MA

    Sonya Narla DO, MA is a current PGY-3 Family Medicine Resident at the University of Rochester. Dr. Narla attended Case Western Reserve University and graduated with a Bachelor's Degree in English and Master's Degree in Biomedical Ethics in 2011. She then went on to serve as Executive Director of a global health non-profit in West Africa. She recieved her DO from Lake Erie College of Osteopathic Medicine in Erie, PA. She has special interests in global health, underserved health populations, academic family medicine, and optimizing primary care. She has published several articles in Family Doctor, a journal of NYS Academy of Family Physicians, including an article on the Choosing Wisely Guidelines on Controlled Medications in Common Clinical Scenarios. 

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Value-based Payment Models to Address the Opioid Overdose Crisis (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about effective payer/provider relationships that are crucial in selecting payment models that fit the needs of individual practice from The ASAM 50th Annual Conference (2019).

    (1 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Since 1999, there has been a growing epidemic across the United States of deaths due to opioid overdoses. Despite a substantial amount of literature documenting the clinical effectiveness of medication, in combination with medical and psychosocial supports, as an effective treatment for addiction involving opioid use, this treatment method is significantly underutilized due to several problems with the existing healthcare payment and financing infrastructure. Of the estimated 2.1 million people who need treatment for addiction involving opioid use, only a small fraction of this population ultimately receives specialty treatment. While there have been several efforts aimed at addressing this public health crisis, value-based payment methodologies have emerged as an innovative solution to these systematic barriers to quality treatment. This session will provide attendees with an explanation of how addiction treatment is currently financed, explore the many problems with current payment systems, and address the need for value-based payment strategies that have the potential to improve patient outcomes and reduce spending for opioid addiction by overcoming existing barriers. Panelists will discuss the barriers that limit the availability and widespread adoption of alternative payment models. They also will look at efforts by insurers and other stakeholders to overcome barriers and use value-based payment models to enhance quality care, and ultimately expand access to addiction treatment. This session will also offer insight into effective payer/provider relationships that are crucial in selecting payment models that fit the needs of individual practices, demonstrate fiscal responsibility, and ensure that patients continue to receive access to critical care.




    Shawn Ryan

    MD, MBA, FASAM

    Dr. Shawn Ryan originally trained as an emergency physician at the University of Cincinnati and simultaneously obtained his MBA while completing his residency. For over 10 years, Dr. Ryan has practiced in the Greater Cincinnati area, and for part of that period, he functioned as a hospital administrator.  During this time, he became acutely aware of the issue of heroin/opioid abuse in the region and for the past 7 years has been working tirelessly to make a difference in his community. Dr. Ryan serves on many regional, state, and national committees/workgroups focused on turning the tide of this epidemic.  He is the immediate-past president of the Ohio Society of Addiction Medicine and the current Chair of Payer Relations for ASAM.  Dr. Ryan is very excited to continue to work in the field of addiction medicine and to have the opportunity to substantially impact the treatment needs of patients with substance use disorder.

    Amanda Mauri

    MPH

    Amanda is a PhD student in the Health Management and Policy Department at the University of Michigan School of Public Health. Her research focuses on issues related to behavioral health policy domestically and abroad. Specifically, she combines political science and health services research methods to evaluate national and local policies related to insurance equity, opioid misuse, and behavioral health provider shortages. At Shatterproof, Amanda works on a variety of initiatives related to MAT payment practices.   Previously, Amanda worked as the Policy Advisor at the Kennedy Forum and Thomas Scattergood Behavioral Health Foundation. In this position, she analyzed legislative and regulatory actions related to behavioral health insurance coverage. She mainly focused on behavioral health parity implementation, providing technical assistance to health plans and regulatory agencies and assisting in the development of accreditation standards and auditing protocols.   Prior to starting this position, Amanda was the senior researcher on A Common Struggle by Patrick Kennedy and Stephen Fried. In this role, she researched the development of U.S. mental health policy from 1960s to today and co-authored a roadmap to improve the U.S. behavioral health system featured in the appendix. Amanda received both a Bachelor's Degree in Health and Society and a Master's Degree in Public Health from the University of Pennsylvania.

    Debra Nussbaum

    PhD, LCSW

    Debra Nussbaum, PhD, LCSW Sr. Director, Behavioral Product Optum/UHC Deb started with Optum in 2009 as Director of Clinical Operations.  In 2013 Deb moved into national role as a Sr. Director of Behavioral Health Product. Deb is a co-founder and clinical lead for Optum’s national substance use disorder (SUD) initiatives. Deb has successfully championed many projects within Optum designed to improve member access to evidence based services, the development of the nation’s largest MAT network and the 24/7 SUD helpline and live chat capabilities. Debra’s clinical background has been primarily in substance use services in progressive leadership roles managing and developing treatment programs aimed at improving outcomes in addiction treatment services. Deb has a PhD in organizational psychology and is an LCSW licensed in Florida and in New York.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Looking Beyond Addicted Patients: Families and Others as Consumers of Addiction Treatment (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the Physician Health Programs (PHPs) and their standard for success in making treatment work from the 50th Annual Conference (2019).

    This workshop addresses a known but often ignored paradox in the field of addiction treatment: 94% of individuals with a substance use disorder do not think they have a problem and do not want treatment. At the same time illegal drug users in the US spend about $100 billion each year on drugs while they spend virtually nothing on the costs of treatment. All addiction treatment in the US �" both public and private �" costs about $34 billion each year. Not surprisingly, the initial “customer” of addiction treatment and other recovery-oriented services is often the family or other interested parties who have serious concerns about the drug use of an addicted person. The customer of treatment can also be an employer, a healthcare professional, a school-based professional or the criminal justice system, among other many others. The concern for the role of others in the fragile recovery process is underlined by the experiences of the nation’s state Physician Health Programs (PHPs) which set the standard for success in making treatment work and in making five-year recovery the expected outcome. The role of the PHP care management extends from intervention, through evaluation to treatment and then to sustained monitoring to identify relapses and to ensure prompt intervention, which are all crucial to this success. While complying with this comprehensive care management PHPs offer to addicted physicians safe haven from the consequences of their addictive behaviors which would otherwise be imposed by the state medical boards. When looking for similar leverage in the lives of addicted patients, the most obvious place to start is the family. Families often expect episodes of treatment to “fix” the addicted family member. The reality is far different: long-term recovery commonly requires long-term care management and active, continuous recovery support. For many addicted people that calls for family action that is rarely achieved by “detaching with love.” This workshop identifies the implications for public health efforts to reduce drug demand and to rescue addicted people from the escalating damage done by their continued drug use. Efforts to curb addiction must educate and empower families and other interested parties to skillfully navigate the system of addiction treatment and health care �" not only to get addicted people into the treatment they need but also to actively monitor their behavior after treatment to support and sustain long-term recovery. The nation’s state PHPs reliably produce sustained recovery long after formal treatment has ended. They offer useful lessons in the essential elements of this new paradigm of recovery for families.

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:



    Learning Objectives:

    1.) Identify opportunities for the initial “customers” of addiction treatment to assist patients treated for addiction to achieve and sustain long-term recovery.
    2.) Articulate the essential elements of the physician health programs.
    3.) Emphasize the importance of sustained monitoring by the family for any drug use and for continued active participation in recovery support for five years from the onset of treatment.  



    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Recovering Through the End: Managing Addiction in Hospice and Palliative Care (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about epidemiology of SUD among patients with serious illness, and describe existing models of care for individuals with serious illness, including palliative care and hospice from the 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Individuals with opioid use disorder and other addictions have a high mortality rate, not only from causes directly related to their use, but also from heart disease, cancer, and COPD, among other illnesses.   Patients with addiction who develop advanced cancer and other serious diseases may be less able to participate in treatments for their addiction, and often develop pain that prompts opioid prescribing.  However, with medical advances, the “dying” phase has become longer. Patients with serious illness may live months and years longer than they might have 20 to 30 years ago.  The combination of unlimited opioid prescribing and decreased participation in addiction treatment as individuals get sicker often creates chaos among patients and families and distress for medical providers. This session, led by a physician who is board certified in both hospice and palliative medicine and addiction medicine, will review the epidemiology of substance use disorder among patients with serious illness, and describe existing models of care for individuals with serious illness, including palliative care and hospice.  Through clinical cases, we will discuss the rationale for continuing addiction treatment in patients with serious illness, and we will learn of models for collaborating with hospice and palliative medicine providers in the care of this population.   



    Learning Objectives:

    1.) Upon completion, participants will be able to describe the importance of addressing addiction in individuals with serious illness.  
    2.) Upon completion, participants will be able to describe services provided by hospice and palliative care in the United States.
    3.) Upon completion, participants will be able to collaborate with hospice and palliative medicine care providers in the care of individuals with addiction and serious illness.  



    Julie Childers

    MD

    Julie Childers, MD, is a board certified physician in hospice and palliative medicine and a medical educator at the University of Pittsburgh.      In 2010, while continuing to practice in inpatient palliative medicine, she founded an outpatient opioid use disorder clinic, where she continues to see patients one half day a week.    In 2018, she became board certified in Addiction Medicine through the American Board of Preventative Medicine. She is a member of the Motivational Interviewing Network of Trainers and has developed MI curricula for medical students, residents, fellows, and practicing physicians.  She is regularly asked to speak nationally and locally to palliative care professionals on managing pain in patients with opioid use disorder and addiction.  Her research interests include the overlap between pain and addiction, particularly in individuals with serious illness who are receiving palliative care.    

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Anywhere, Anytime: Model for Universal Access to Opioid Medication Assisted Treatment (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the process and unique challenges in connecting patients to care from different clinical settings from the 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Opioid overdoses continue to climb. In 2016, 116 people died every day from opioid related overdose (NIDA, 2018). Medication Assisted Treatment (MAT) improves morbidity and mortality in patients with opioid use disorder, but only 10% of patients with a substance use disorder are in treatment (SAMHSA, 2017). Patients face many difficulties accessing MAT including stigmatization, wait times, difficulty finding a doctor, continued withdrawal, and payment limitations. Critically, patients are typically unable to access treatment at the moment they seek to stop using. The decisions to pursue sobriety often comes at the most inopportune times: for example, in the middle of the night when heroin dealers are available but admission to treatment is not.  When they do encounter the healthcare system, most patients are left merely with a phone number to call. In order to facilitate access to treatment, Denver Health and Hospital Authority has developed a hub-and-spoke system leveraging a narcotic treatment program to facilitate access to MAT. To date in 2018, we have started 385 patients on MAT including from the emergency departments and psychiatric emergency service (n=181, 47%), jail and forensic settings (n=40, 10%), acute inpatient medicine (n=52, 14%),  and a social detoxification service (n=32, 8%).  Each referral source requires innovative clinical processes to identify patients with opioid use disorders, evaluate for MAT eligibility, and initiate treatment. In addition to being ideal for the patient, MAT-on-demand reduces the intake burden on outpatient services as well. With this model, Denver residents can access opioid MAT 24 hours a day�"there is no wrong door and no wrong time to access care. We present the development of this model in an integrated hospital and outpatient safety net system including clinical processes, staff training, and financing. A case-based presentation illustrates the process and unique challenges in connecting patients to care from different clinical settings. While the overall 30 day treatment retention is 48%, retention varies significantly by referral source, from 15% to 67% (p  


    Learning Objectives:

    1.) Describe challenges facing health systems and individual providers for delivering addiction treatment
    2.) Describe how a Hub and Spoke Model facilitates patient’s entry into medically assisted opioid treatment  and describe clinical dilemmas in the aggressive extension of MAT in highly acute medical and psychiatric care settings.
    3.) Understand aspects of program developing including cultivating partnership with substance abuse treatment programs 



    Dayan Dachel Colon Sanchez

    MD

    Dr. Dayan Colon Sanchez, is the Medical Director of the Methadone Clinic and Adult Substance Treatment Services at Denver Health and Hospital Authority, the safety-net hospital for Denver, CO. She went to medical school at Temple University and completed a general psychiatry residency and an addiction psychiatry fellowship at the University of Colorado. Dr. Colon Sanchez is passionate about improving access to Medication Assisted Treatment for patients with opioid use disorders. 

    Scott Simpson

    MD MPH

    Scott Simpson MD is Medical Director of Psychiatric Emergency Services at Denver Health Medical Center and Assistant Professor of Psychiatry at the University of Colorado School of Medicine. Dr. Simpson has published on the management of substance use disorders in the emergency setting and part of the Denver Health team that launced Colorado's first 24/7 buprenorphine induction program. Dr. Simpson is board certified in general psychiatry, addiction medicine, and consultation-liaison psychiatry.

    Hermione Hurley

    MD

    Dr Hurley is an Infectious Disease, Addiction Medicine physician at Denver Health and Assistant Professor of Medicine at the University of Colorado. Her interest in substance care began after observing poor health outcomes for justice involved individuals at Denver Health Correctional Care Medical Facility. Her subsequent decision to pursue fellowships in Infectious Disease and then Addiction Medicine was motivated by the high prevalence of infectious disease and substance use disorders among individuals who are recently released from jail or prison. Her current position at Denver Health is supported by both Psychiatry and Medicine departments to increase treatment for individuals irrespective of where they seek care, be it the ID or methadone clinic.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Cook County Medical Examiner/Clinical Data Linkage to Inform Overdose Prevention Strategy (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about overdose prevention strategy gathered from Cook County, IL clinical data from the 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Background: Over 49,000 individuals in the U.S. died from opioid overdose in 2017 [1]. In Illinois half of all opioid fatalities occurred in Cook County in 2016 [2]. Buprenorphine and methadone have been shown to reduce mortality among individuals surviving an opioid overdose [3]. Naloxone is a safe and effective medicine for opioid overdose reversal [4]. Cook County Health (CCH) is a large safety-net healthcare system based in Chicago IL. It comprises a 464-bed tertiary-care hospital, an emergency department with over 120,000 visits annually, a network of 14 community health centers, Cermak Health Services (providing healthcare to detainees at Cook County Jail), the public health department for suburban Cook County, and a Medicaid Managed Care Community Network. CCH serves a vital role for many patients at highest risk of fatal illicit opioid overdoses. Recognizing increased health care utilization preceding overdoses [5], we characterized all CCH community- and corrections-based clinical encounters that preceded fatal opioid overdoses in 2017 to help inform novel prevention strategies. Methods: All 2017 cases of illicit opioid fatalities in the Cook County medical examiner’s database were merged with CCH electronic health records. For matching records of decedents we obtained encounter history and ICD10 diagnosis codes. We characterized decedents and their CCH clinical encounters within 12 months of their fatality. Separately for ED visits, hospitalizations, clinic encounters, and detentions in jail, we assessed time between encounter and death, whether or not opioid use disorder was identified as a contributory diagnosis, and co-morbid conditions. Results: Cook County Medical Examiner data revealed 1017 overdose deaths in 2017 attributed to heroin and/or fentanyl.  There were 663 overdose deaths attributed to fentanyl.  Sixty-nine percent (n = 706) of all decedents had a documented CCH encounter within 15 years of fatal overdose, and 18% (n=181) had a documented encounter within 12 months. Of these 181, 49% died within 100 days of their final encounter, and 25% within 30 days.  Among decedents with a CCH encounter within 12 months of death, 133 (73%) were associated with �-1 ICD10 diagnosis codes; 57% and 32% with substance use disorder and opioid use disorder, respectively.  The two most common diagnosis codes were hypertension and “encounter for issue of repeat prescription refill”.  Among diagnoses recognized in the ED, “encounter for issue of repeat prescription refill” accounted for 20% of encounters. Conclusions/Discussion: Our analysis highlights important questions for a healthcare system seeking to improve its approach to opioid overdose prevention.  Where are the missed opportunities for intervention?  Does screening effectively recognize patients with opioid use disorder and enable care teams to implement overdose prevention systematically? What revisions to current care processes would improve access to proven overdose prevention interventions?  How accessible are treatment and overdose prevention resources for patients at highest risk of overdose?  During this session, we will introduce system improvement efforts identified and supported by this research across the domains of screening, risk stratification, and transitions of care. Practical implications will be reviewed for application to other healthcare systems.  



    Learning Objectives:

    1.) Describe the key findings from clinical and medical examiner opioid overdose data integration in Cook County, IL and its application to other jurisdictions. 
    2.) Identify potential healthcare system improvements and process changes informed by the clinical/medical examiner overdose data integration.
    3.) Demonstrate understanding of the opportunity and limitations related to medical examiner overdose and clinical data integration. 



    James Raspanti

    DO

    James Raspanti, DO is a second year family medicine resident at Cook County Health in Chicago, IL.  On top of an interest in full-spectrum family medicine, he has focused on acquiring skills in substance use treatment to better meet the needs of his patients.  His research interests include understanding healthcare utilization by patients with substance use disorder, creating structure for resident participation in MAT, and integrated care teams.

    Juleigh Nowinski Konchak

    MD, MPH

    Juleigh Nowinski Konchak MD MPH is a physician leader for the medication-assisted treatment (MAT) Collaborative at Cook County Health.  Juleigh is also core faculty for the Preventive Medicine Residency Program at CCH.   Juleigh recently served as Medical and Community Health Lead for Addiction Services at Heartland Health Outreach, a healthcare for the homeless federally-qualified health center in Chicago.  She has a master in public health degree from Northwestern University, completed her preventive medicine and public health residency at CCH in conjunction with Northwestern University, and attended the University of Illinois at Chicago College of Medicine.  Prior to her medical training, Juleigh held several public sector roles in policy and public health including Director of Health Systems Integration with the Chicago Department of Public Health,  Special Assistant to the Assistant Secretary for Health at the U.S. Department of Health and Human Services, and Health Policy Legislative Assistant at the Office of then-U.S. Senator Barack Obama. 

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.